Quantcast
Last updated on April 21, 2014 at 11:58 EDT

Latest Boston Scientific Corporation Stories

2013-05-22 12:30:35

New Data Presented In Late-Breaking Clinical Trial Session At EuroPCR Demonstrated Successful Deployment Of The Lotus(TM) Valve In The First 60 Patients With Minimal Paravalvular Regurgitation At 30 Days PARIS, May 22, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reports positive results from a pre-specified analysis of the first 60 patients enrolled in the REPRISE II trial evaluating the performance and safety of the Lotus(TM) Valve System in symptomatic patients...

2013-05-22 08:29:49

PARIS, May 22, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reports positive results from two trials evaluating new, innovative drug-eluting stent (DES) technologies, which are emerging treatment options for coronary heart disease. Data from the first human use NG PROMUS Clinical Trial evaluating the safety and effectiveness of the Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System, and two-year follow-up data from the EVOLVE Trial comparing the...

2013-05-21 12:28:25

NATICK, Mass., May 21, 2013 /PRNewswire/ -- Five-year data from the Asthma Intervention Research 2 (AIR2) clinical trial presented today demonstrated that the Boston Scientific Corporation (NYSE: BSX) Alair(® )Bronchial Thermoplasty (BT) System continues to show therapy benefits in adult patients with severe uncontrolled asthma. Bronchial Thermoplasty was shown to provide long term asthma control, demonstrated by a sustained reduction in the rate of severe exacerbations (asthma attacks)...

2013-05-21 04:21:05

WIESBADEN, Germany, May 21, 2013 /PRNewswire/ -- Medical device manufacturer OrbusNeich Medical Inc. and its subsidiary, OrbusNeich Medical GmbH (collectively "OrbusNeich") today announced that it has enforced the seizure of over 190 stent systems from Boston Scientific Corporation (NYSE: BSX) in connection with its patent infringement proceedings in the Dusseldorf Regional Court. The products were found on May 15, 2013, at the premises of Boston Scientific Medizintechnik GmbH in Ratingen...

2013-05-17 08:26:56

HONG KONG, May 17, 2013 /PRNewswire/ -- Insiderslab.com has issued insider trading reports for investors of US market. Today's report includes NetApp (NASDAQ:NTAP), Facebook (NASDAQ:FB), Advanced Micro Devices (NYSE:AMD), Boston Scientific (NYSE:BSX), Hess (NYSE:HES), and Cliffs Natural Resources (NYSE:CLF). (Logo: http://photos.prnewswire.com/prnh/20130401/HK85662LOGO) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)...

2013-05-17 08:24:19

NATICK, Mass., May 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in Digestive Disease Week (DDW®) 2013, May 18-21 in Orlando, Fla. More than 24 clinical presentations will feature new data and analyses on products including the Boston Scientific SpyGlass® Direct Visualization System, WallFlex® Biliary RX Stent System and Expect® 19 Flex Endoscopic Ultrasound Aspiration Needle. "The insights and data included in these...

2013-05-17 04:20:42

NATICK, Mass., May 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate at the annual EuroPCR Scientific Program May 21-24 in Paris. "We are pleased to present a particularly rich and diversified set of data this year at EuroPCR," said Keith Dawkins, M.D., global chief medical officer, Boston Scientific. "The primary endpoint results for several trials will be presented, including the NG PROMUS trial, which evaluated our Promus PREMIER((TM)) Stent...

2013-05-15 12:34:32

Study Evaluates Clinical Outcomes of Self-Expanding Metal Stents as a Bridge to Surgery NATICK, Mass., May 15, 2013 /PRNewswire/ -- The first patient has been enrolled in a clinical investigation evaluating the use of the Boston Scientific Corporation (NYSE: BSX) WallFlex® Biliary RX Stent, a self-expanding metal stent (SEMS), as a bridge to surgery compared with the absence of drainage prior to surgery. This multi-center, prospective, randomized study is expected to enroll 294...

2013-05-10 16:25:17

Industry-Leading Battery Life Reduces the Frequency of Replacement Surgery NATICK, Mass., May 10, 2013 /PRNewswire/ -- New data from 100,438 patients with Boston Scientific Corporation (NYSE:BSX) implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) followed in the LATITUDE(TM)( )Patient Management System demonstrate the battery life of Boston Scientific single-chamber ICDs, dual-chamber ICDs and CRT-Ds are projected to last an...

2013-05-10 08:29:38

HONG KONG, May 10, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports for the following hot stocks: Advanced Micro Devices (NYSE:AMD), Monster Beverage (NASDAQ:MNST), Apache (NYSE:APA), Rackspace Hosting (NYSE:RAX), Oracle (NASDAQ:ORCL), and Boston Scientific (NYSE:BSX). (Logo: http://photos.prnewswire.com/prnh/20130417/HK96241LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report...